Neurotoxicity of high-dose methotrexate in the treatment of non-Hodgkin’s lymphomas in children: clinical and genetic aspects
Backround. Treatment protocols for non-Hodgkin’s lymphomas in pediatric patients include a combination of cytotoxic drugs, with methotrexate (MTX) playing a central role, often administered in high doses (1000–5000 mg/m2). MTX is associated with a wide range of side effects, manifesting as organ tox...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2025-05-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/1037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!